Myoclonic jerks and inattentiveness may be rare neurologic complications of ATO toxicity. Clinicians must be aware of this rare toxicity given that the ATO and ATRA combination is now standard-of-care treatment of low-risk APL.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595259 | PMC |
http://dx.doi.org/10.1182/bloodadvances.2019000249 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!